ANDA 78711, held by Sandoz. Medroxyprogesterone Acetate.
As of Nov 16, 2026, ANDA 78711 (Medroxyprogesterone Acetate), held by Sandoz, was first approved by FDA on May 20, 2009, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 20, 2009 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Medroxyprogesterone Acetate150MG/ML ยท injectable;injection | Medroxyprogesterone Acetate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters